Symposium 01 : Nov. 14 (Thu), 09:00-10:30
Distinguished papers of 2023-2024 in clinical and molecular hepatology

• CMH reports in 2024 Yeonjung Ha
  CHA University, Korea CV ����
• Most viewed article - Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: a nationwide study In Hee Kim
  Jeonbuk National University, Korea CV ����
• Highly cited article - Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: a DALY-based analysis of the global burden of disease 2019 study Seung Up Kim
  Yonsei University, Korea CV ����
• Notable article on clinical research - Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: a nationwide hepatitis C virus registry program Ming-Lung Yu
  Kaohsiung Medical University, Taiwan CV ����
• Notable article on basic/translational research - Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression Kyung Hyun Yoo
  Sookmyung Women's University, Korea CV ����

Presidential Lecture : Nov. 14 (Thu), 11:10-11:40
Chung Yong Kim Memorial Lecture

• Recent update of MASLD Jin Mo Yang
  The Catholic University of Korea, Korea ����

Symposium 11 : Nov. 14 (Thu), 13:20-14:50
Emerging issues in the management of portal hypertension

• Noninvasive diagnosis of portal hypertension and its clinical applications Byeonggeun Song
  Sungkyunkwan University, Korea CV ����
• Albumin as a multiplayer in decompensated liver cirrhosis Yu Jun Wong
  Changi General Hospital, Singapore CV ����
• Personalized beta-blocker therapy in liver cirrhosis: pros and cons Moon Young Kim
  Yonsei University Wonju, Korea CV ����
• Evaluation and management of cardiovascular manifestations in end-stage liver diseases Jae Sik Park
  The Catholic University of Korea, Korea CV ����

Basic/Translational Symposium : Nov. 14 (Thu), 13:20-14:50
Advancements in liver research: from experimental models to clinical insights and therapeutic targets

• Recent update of in vitro/ex vivo experiment for studying liver disease Young-Sun Lee
  Korea University, Korea CV ����
• Research insights into hepatic metabolism and carcinogenesis using human biospecimen Hyuk Soo Eun
  Chungnam National University, Korea CV ����
• Targeting gut-liver axis: new aspect of understanding chronic liver diseases Hail Kim
  KAIST, Korea CV ����
• Molecular connection between liver disease and cardiovascular disorders Myeong Jun Song
  The Catholic University of Korea, Korea CV ����

Symposium 12 : Nov. 14 (Thu), 15:10-16:40
Careful insights for benign hepatic neoplasm

• Clinical and radiological implications of indeterminate hepatic nodules in patients with cirrhosis Seung-seob Kim
  Yonsei University, Korea CV ����
• Subtypes and their prognostic impact of Hepatocellular adenomas Valérie Paradis
  Université Paris Cité, France CV ���ã��
• Hepatic angiomyolipoma and perivascular epithelioid cell tumor family in the liver: dangers of misdiagnosis with HCC In Hye Song
  University of Ulsan, Korea CV ����
• Precursor lesions of cholangiocarcinoma: Hepatologist needs to know Yasuni Nakanuma
  Fukui Prefecture Saiseikai Hospital, Japan CV ����

Symposium 17 : Nov. 15 (Fri), 10:20-11:50
Update and latest advances in systemic treatment for HCC

• Adverse events of atezolizumab and bevacizumab in HCC: risk factors and dose modification Sangyoun Hwang
  Dongnam Institute of Radiological & Medical Sciences (DIRAMS), Korea CV ����
• Imaging biomarkers for response evaluation of atezolizumab and bevacizumab in HCC Kyowon Gu
  Sungkyunkwan University, Korea CV ����
• Adjuvant and combined roles of systemic treatment in HCC Yu Rim Lee
  Kyungpook National University, Korea CV ����
• Blood- and tissue-based tools to guide optimal systemic treatment in HCC Stephen Lam Chan
  The Chinese University of Hong Kong, Hong Kong CV ����

Symposium 14 : Nov. 15 (Fri), 8:30-10:00
Sarcopenia in liver diseases: from molecular insights to clinical strategies

• Comprehensive assessment of sarcopenia and frailty: how and by which tools? Bo Kyung Koo
  Seoul National University, Korea CV ����
• Sarcopenia in cirrhosis: from pathogenesis to prognosis Sae Kyung Joo
  Seoul National University, Korea CV ����
• Sarcopenia in MASLD : an altered liver-muscle crosstalk Sung Hwan Yoo
  Yonsei University, Korea CV ����
• Multidisciplinary therapeutic strategies for sarcopenia Do Seon Song
  The Catholic University of Korea, Korea CV ����

USG02 : Nov. 16 (Sat), 10:20-11:50
Abdominal US training specialist 2

• Local ablation for patients with hepatocellular carcinoma: Korean expert consensus-based practice Dong Ho Lee
  Seoul National University, Korea CV ����
• A comparison of endoscopic ultrasound and transabdominal ultrasound in pancreatobiliary disease Huapyong Kang
  Gachon University, Korea CV ����
• Liver application of fusion imaging: real-time virtual sonography (RVS) Min Woo Lee
  Sungkyunkwan University, Korea ����
• Noninvasive tests (NITS) for hepatic fibrosis: us-based elastography Ji Won Han
  The Catholic University of Korea, Korea CV ����

USG01 : Nov. 16 (Sat), 8:30-10:0
Abdominal US training specialist 1

• Preparing for ultrasound education: tips and recommendations Seul Ki Han
  Yonsei University Wonju, Korea ����
• Learning goal and outcomes of ultrasound education Jeong Eun Song
  Daegu Catholic University, Korea ����
• Echocardiography education: what to imitate? Dae-Hee Kim
  University of Ulsan, Korea CV ����
• A comparison of point of care ultrasound and conventional ultrasound Young Soon Cho
  Soonchunhyang University, Korea CV ����